Boenning & Scattergood, Inc. Abb Vie Inc. Transaction History

Boenning & Scattergood, Inc.

$622 Million
Q4 2022

A detailed history of Boenning & Scattergood, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Boenning & Scattergood, Inc. holds 80,679 shares of ABBV stock, worth $13.8 Million. This represents 2.1% of its overall portfolio holdings.

Number of Shares

80,679

Previous 69,285 16.45%

Holding current value

$13.8 Million

Previous $9.3 Million 40.65%

% of portfolio

2.1%

Previous 1.9%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	BUY	$138.31 - $165.87 $1.58 Million - $1.89 Million	11,394 Added 16.45%	80,679 $13.1 Million
Q3 2022 Oct 11, 2022	SELL	$134.21 - $153.93 $1.3 Million - $1.5 Million	-9,715 Reduced 12.3%	69,285 $9.3 Million
Q2 2022 Jul 13, 2022	SELL	$137.62 - $174.96 $231,063 - $293,757	-1,679 Reduced 2.08%	79,000 $12.1 Million
Q1 2022 Apr 14, 2022	SELL	$131.98 - $163.75 $102,152 - $126,742	-774 Reduced 0.95%	80,679 $13.1 Million
Q4 2021 Jan 18, 2022	SELL	$107.43 - $135.93 $162,326 - $205,390	-1,511 Reduced 1.82%	81,453 $11 Million

Q3 2021 Oct 21, 2021	SELL	$106.4 - $120.78 $424,642 - $482,032	-3,991 Reduced 4.59%	82,964 $8.95 Million
Q2 2021 Jul 21, 2021	BUY	$105.21 - $117.21 $326,151 - $363,351	3,100 Added 3.7%	86,955 $9.8 Million
Q1 2021 Apr 22, 2021	BUY	$102.3 - $112.62 $537,381 - $591,592	5,253 Added 6.68%	83,855 $9.08 Million
Q4 2020 Jan 20, 2021	SELL	$80.49 - $108.67 $23,020 - $31,079	-286 Reduced 0.36%	78,602 $8.42 Million
Q3 2020 Oct 21, 2020	BUY	$85.91 - $100.83 $13,058 - $15,326	152 Added 0.19%	78,888 $6.91 Million
Q2 2020 Jul 14, 2020	BUY	$73.37 - $98.18 $88,117 - $117,914	1,201 Added 1.55%	78,736 $7.73 Million
Q1 2020 Apr 13, 2020	SELL	$64.5 - $97.79 $68,305 - $103,559	-1,059 Reduced 1.35%	77,535 $5.91 Million
Q4 2019 Jan 15, 2020	BUY	$72.13 - $90.25 $354,807 - $443,939	4,919 Added 6.68%	78,594 $6.96 Million
Q3 2019 Oct 15, 2019	BUY	$62.98 - $75.72 $620,856 - $746,447	9,858 Added 15.45%	73,675 $5.58 Million
Q2 2019 Jul 15, 2019	BUY	$65.7 - $83.98 $154,329 - $197,269	2,349 Added 3.82%	63,817 $4.64 Million
Q1 2019 Apr 22, 2019	BUY	$77.14 - $90.79 $1.22 Million - $1.44 Million	15,857 Added 34.77%	61,468 $4.95 Million
Q4 2018 Jan 22, 2019	SELL	$77.85 - $96.01 $17,127 - $21,122	-220 Reduced 0.48%	45,611 $4.21 Million
Q3 2018 Oct 05, 2018	SELL	$88.91 - $98.84 $193,912 - $215,570	-2,181 Reduced 4.54%	45,831 $4.34 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $4.31 Million - $5.1 Million	48,012 New	48,012 $4.45 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boenning & Scattergood, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Boenning & Scattergood, Inc. with notifications on news.

Account

Boenning & Scattergood, Inc. Abb Vie Inc. Transaction History